Gala Araujo, Agata Martin-Ozimek, Leidy Valencia, Yosdel Soto, Spencer Proctor. Immunogenicity of novel variants of the chimeric chP3R99 antiatherogenic antibody in insulin-resistant rats. Poster presentation. Alberta Diabetes Institute (ADI) Research Day 2023, University of Alberta, Edmonton, Alberta, Canada. Gala Araujo, Read More …
Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F. Vine, Ana M. Vázquez, Spencer D. Proctor. Novel chP3R99 mAb reduces subendothelial retention of atherogenic lipoproteins in Insulin-Resistant rats: Acute treatment versus long-term protection as an idiotypic vaccine for atherosclerosis To read the article please click here: https://doi.org/10.1101/2023.08.30.555546
Agata Martin-Ozimek, Gala Araujo, Spencer Proctor, Yosdel Soto. Immunogenicity of A Novel Cardiovascular Therapy: CHP3R99 MAB. 2023 Nutrition Research Poster Symposium, Edmonton, Alberta, March 29, 2023.
Proctor SD, Lopez YS. A Novel Antibody with Vaccine-like Properties to Treat Heart Disease in Diabetes. Scientia. February 2021 “Patients with diabetes mellitus face an increased risk of developing heart disease. The high levels of sugars, lipid and cholesterol associated Read More …
We have now translated our Cardio Vacc Novel Antibody animation video into Mandarin and Spanish.
Animation Series Part 1: NOVEL ANTIBODY
To watch the Healthy Heart Animation Series in English click here. To watch the Healthy Heart Animation Series in Mandarin click here. To watch the Healthy Heart Animation Series in Spanish click here.
Try our new remnant cholesterol calculator by clicking here.
Atherosclerosis affects millions of individuals each year, particularly those with insulin resistance and diabetes. It results from the accumulation of lipids and cholesterol in arterial vessels that lead to the formation of obstructive deposits. These deposits, known as plaques, limit Read More …
